Diakonos Oncology doses first patients in DOC-RM trial
Key endpoints of the trial include safety, objective response, levels of circulating tumour deoxyribonucleic acid.
Clinical Trials
Moleculin reports interim results from MIRACLE trial in r/r AML patients
Karyopharm’s XPORT-EC-042 study fails to meet primary endpoint
Evommune begins Phase IIb trial of EVO756 for migraine
Massive Bio and QC Healthcare join forces for cancer trial access
Estrella activates new site in Texas for STARLIGHT-1 Phase I/II trial
ICON partners with Anthropic to integrate Claude AI in clinical trials
Atea reports positive topline results in Phase III hepatitis C study
